AstraZeneca's Baxdrostat met the primary and all secondary endpoints in BaxHTN Phase III trial
Baxdrostat demonstrated a statistically significant and clinically meaningful reduction of systolic blood pressure compared with placebo
Baxdrostat demonstrated a statistically significant and clinically meaningful reduction of systolic blood pressure compared with placebo
Innovative product offerings to capitalise on emerging opportunities within and beyond the sexual wellness market
Glycopyrrolate Oral Solution is an anticholinergic medication indicated for pediatric patients
This strategic move aims to make Cupid's high-quality products more accessible to consumers nationwide
Tacrolimus is an immunosuppressant used in the treatment of organ transplant patients
The launch will enable PCC to further expand their existing Zinc Sulfate Injection product line and overall the generic injectables portfolio
The company expects this approval in Baddi to pave the way for GMP certifications from European Medicines Agency and other PIC/S member nations
The company has launched its new range of 25 allopathy ophthalmic products including GUERIMOD, GUERIPRED, BIMATO MST etc. for curing various diseases related to eyes
According to industry sales data, Yondelis generated annual sales of $49.7 million for the twelve months ending June 2022 in the US market.
It is only the second generic application approved by the USFDA
Subscribe To Our Newsletter & Stay Updated